• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies.

作者信息

Hashem Hasan, Rihani Rawad, Shanap Mayada Abu, Khattab Eman, Tbakhi Abdelghani, Sultan Iyad

机构信息

Pediatric Hematology Oncology and Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.

Department of Cellular Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan.

出版信息

Bone Marrow Transplant. 2022 Feb;57(2):304-305. doi: 10.1038/s41409-021-01536-y. Epub 2021 Nov 27.

DOI:10.1038/s41409-021-01536-y
PMID:34839361
Abstract
摘要

相似文献

1
Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies.用于患有严重再生障碍性贫血且有供体特异性抗HLA抗体的儿童进行单倍体相合造血细胞移植的新型预处理方案。
Bone Marrow Transplant. 2022 Feb;57(2):304-305. doi: 10.1038/s41409-021-01536-y. Epub 2021 Nov 27.
2
Research advances on haploidentical hematopoietic stem cell transplantation in the treatment of severe aplastic anemia in children.儿童重型再生障碍性贫血单倍体造血干细胞移植治疗的研究进展。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Aug 15;23(8):854-859. doi: 10.7499/j.issn.1008-8830.2105073.
3
Upfront Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Children With Severe Aplastic Anemia.采用移植后环磷酰胺的单倍体相合干细胞早期移植治疗儿童重型再生障碍性贫血
J Pediatr Hematol Oncol. 2020 Nov;42(8):500. doi: 10.1097/MPH.0000000000001957.
4
Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.在儿童获得性再生障碍性贫血中，与其他供者类型的移植相比，优化的单倍体造血干细胞移植具有更快的植入效果和可比的结果。
Biol Blood Marrow Transplant. 2019 May;25(5):965-974. doi: 10.1016/j.bbmt.2019.01.010. Epub 2019 Jan 11.
5
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.环磷酰胺预处理的亲缘单倍体造血干细胞移植治疗复发/难治性重型再生障碍性贫血中 CD34 细胞剂量和预处理方案对结局的影响。
Biol Blood Marrow Transplant. 2020 Dec;26(12):2311-2317. doi: 10.1016/j.bbmt.2020.09.007. Epub 2020 Sep 17.
6
[Haploidentical hematopoietic stem cell transplantation in the treatment of acquired aplastic anemia in children: a single center retrospective analysis].[单倍体相合造血干细胞移植治疗儿童获得性再生障碍性贫血：单中心回顾性分析]
Zhonghua Er Ke Za Zhi. 2018 Jul 2;56(7):529-533. doi: 10.3760/cma.j.issn.0578-1310.2018.07.011.
7
Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia.减低强度预处理联合单倍体相合造血干细胞与间充质干细胞移植治疗重型再生障碍性贫血患者
PLoS One. 2014 Mar 3;9(3):e89666. doi: 10.1371/journal.pone.0089666. eCollection 2014.
8
A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.一项关于人类白细胞抗原单倍体造血干细胞移植联合同种异体间充质干细胞输注治疗儿童和青少年重型再生障碍性贫血的研究。
Stem Cells Transl Med. 2021 Feb;10(2):291-302. doi: 10.1002/sctm.20-0345. Epub 2020 Sep 25.
9
[Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].[一线单倍体相合造血干细胞移植与挽救性单倍体相合造血干细胞移植治疗重型再生障碍性贫血患者的比较]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Oct;28(5):1683-1688. doi: 10.19746/j.cnki.issn.1009-2137.2020.05.042.
10
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.再生障碍性贫血的异基因造血干细胞移植：当前的适应证及移植策略
Blood Rev. 2021 May;47:100772. doi: 10.1016/j.blre.2020.100772. Epub 2020 Oct 31.

引用本文的文献

1
Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia.比较造血干细胞移植和重复强化免疫抑制治疗作为复发/难治性重型再生障碍性贫血的二线治疗。
Front Immunol. 2024 Aug 16;15:1425076. doi: 10.3389/fimmu.2024.1425076. eCollection 2024.
2
The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia.在获得性再生障碍性贫血的单倍体相合造血干细胞移植中，继发性不良移植物功能的发生率、结局和危险因素。
Front Immunol. 2022 May 9;13:896034. doi: 10.3389/fimmu.2022.896034. eCollection 2022.